Cataract News and Research

Latest Cataract News and Research

Takeda announces positive Phase 3 ALTA-1L data in first-line therapy for advanced ALK+ NSCLC

Takeda Pharmaceutical Company Limited today announced that intracranial efficacy data from the Phase 3 ALTA-1L (ALK in Lung Cancer Trial of BrigAtinib in 1st Line) trial showed improved intracranial progression-free survival (PFS) and intracranial objective response rate (ORR) with ALUNBRIG (brigatinib) compared to crizotinib among anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer (NSCLC) patients.

22 Oct 2018

Zebrafish study uncovers molecular 'brake' that helps control eye lens development

How different cells in a multicellular organism acquire their identities remains a fundamental mystery of development. In the eye, for example, the lens contains two cell types - lens epithelial cells and lens fiber cells -- the first of which differentiates into the second as an animal matures.

16 Oct 2018

$Study assess potential impacts of cataracts on risks of osteoporosis and fractures$

Study assess potential impacts of cataracts on risks of osteoporosis and fractures

A new Journal of the American Geriatrics Society study has evaluated the potential impacts of cataracts and cataract surgery on the risks of osteoporosis and bone fractures.

3 Oct 2018

Novel discovery could help to improve success of corneal transplants

A team of eye specialists at The University of Nottingham has made another novel discovery that could help to improve the success of corneal transplants for patients whose sight has been affected by disease.

1 Oct 2018

CHMP adopts positive opinion of Takeda’s ALUNBRIG for treatment of ALK+ non-small cell lung cancer

Takeda Pharmaceutical Company Limited today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has adopted a positive opinion, recommending the full approval of ALUNBRIG® as a monotherapy for the treatment of adult patients with anaplastic lymphoma kinase-positive advanced non-small cell lung cancer previously treated with crizotinib.

24 Sep 2018

CHMP issues positive opinion supporting use of Trelegy Ellipta in broader group of COPD patients

GlaxoSmithKline plc and Innoviva, Inc. announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has issued a positive opinion today supporting the use of Trelegy Ellipta in a broader group of patients with moderate to severe chronic obstructive pulmonary disease and that labeling, if approved, will be updated to further reflect its effect on exacerbations of COPD.

21 Sep 2018

Multi-year study data shows impact of new soft contact lens to slow myopia progression in children

New four-year study data shows the significant impact of a pioneering contact lens management approach to slowing the progression of myopia (nearsightedness) in children, including those whose treatment begins later.

19 Sep 2018

Alcon expands its global support of eye care professionals through Alcon Experience Academy

Alcon, the global leader in eye care and a division of Novartis, is expanding its extensive, global support of eye care professionals through the unveiling of the Alcon Experience Academy.

18 Sep 2018

Swiss Advanced Vision announces launch of Harmonis for cataract surgery

Swiss Advanced Vision has announced the launch of Harmonis, a customizable intraocular lens with advanced extended depth of focus optical technology for cataract surgery.

6 Sep 2018

Less-invasive options are slowing disease progression in glaucoma patients

Judith Smith, now 71, was at a routine appointment several years ago with her longtime ophthalmologist when the doctor made a comment that her right eye looked a little suspicious for glaucoma, an incurable disease that occurs when the optic nerve is damaged by pressure building inside the eye.

17 Aug 2018

FDA expands approval of Vertex' cystic fibrosis medicine to treat children aged 12 to <24 months

Vertex Pharmaceuticals Incorporated today announced the U.S. Food and Drug Administration approved KALYDECO® (ivacaftor) to include use in children with cystic fibrosis ages 12 to <24 months who have at least one mutation in their cystic fibrosis transmembrane conductance regulator gene that is responsive to KALYDECO based on clinical and/or in vitro assay data.

16 Aug 2018

Study finds link between degenerative eye conditions and Alzheimer's disease

Alzheimer's disease is difficult to diagnose as well as treat, but researchers now have a promising new screening tool using the window to the brain: the eye.

9 Aug 2018

Saving sight of millions by making eye injections safe and comfortable

Two eye surgeons have written a first-of-its-kind book to save the sight of millions of patients around the world by making eye injections safe and comfortable.

7 Aug 2018

Omeros’ OMS721 receives positive opinion from EMA's COMP for treating hematopoietic stem cell transplant

Omeros Corporation announced today that the European Medicines Agency's Committee for Orphan Medicinal Products issued a positive opinion recommending orphan drug designation of OMS721 for treatment in hematopoietic stem cell transplantation.

25 Jul 2018

Gene regulator associated with protein pileup in exfoliation glaucoma

In exfoliation glaucoma, a protein dandruff clogs the outflow pathway for the fluid in our eyes.

19 Jul 2018

Ocular Therapeutix resubmits NDA for DEXTENZA

Ocular Therapeutix™, Inc., a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, has announced the resubmission of the Company's New Drug Application to the U.S. Food and Drug Administration for its lead product candidate DEXTENZA™ 0.4mg, for the treatment of ocular pain following ophthalmic surgery.

30 Jun 2018

Cataract surgery linked to modest decrease in risk of serious traffic crash

Cataract surgery was associated with a modest decrease in the risk of being involved in a serious traffic crash.

28 Jun 2018

EyeSouth announces strategic partnership with South Georgia / North Florida Eye Partners

EyeSouth Partners is pleased to announce that it has completed a strategic partnership with South Georgia / North Florida Eye Partners and Cataract and Laser Surgery Center of South Georgia, expanding its presence into the South Georgia and North Florida regions.

8 Jun 2018

FDA approves first stand-alone prosthetic iris in the U.S.

The U.S. Food and Drug Administration today approved the first stand-alone prosthetic iris in the United States, a surgically implanted device to treat adults and children whose iris (the colored part of the eye around the pupil) is completely missing or damaged due to a congenital condition called aniridia or other damage to the eye.

30 May 2018

Celgene to share new and updated data around novel hematological therapies

Celgene Corporation today announced that data from a broad range of early and late stage studies evaluating Celgene investigational agents and investigational uses of marketed products will be presented at the 23rd European Hematology Association annual meeting in Stockholm, Sweden, from June 14-17, 2018.

22 May 2018

Cataract News and Research

Latest Cataract News and Research

Takeda announces positive Phase 3 ALTA-1L data in first-line therapy for advanced ALK+ NSCLC

Zebrafish study uncovers molecular 'brake' that helps control eye lens development

Study assess potential impacts of cataracts on risks of osteoporosis and fractures

Novel discovery could help to improve success of corneal transplants

CHMP adopts positive opinion of Takeda’s ALUNBRIG for treatment of ALK+ non-small cell lung cancer

CHMP issues positive opinion supporting use of Trelegy Ellipta in broader group of COPD patients

Multi-year study data shows impact of new soft contact lens to slow myopia progression in children

Alcon expands its global support of eye care professionals through Alcon Experience Academy

Swiss Advanced Vision announces launch of Harmonis for cataract surgery

Less-invasive options are slowing disease progression in glaucoma patients

FDA expands approval of Vertex' cystic fibrosis medicine to treat children aged 12 to <24 months

Study finds link between degenerative eye conditions and Alzheimer's disease

Saving sight of millions by making eye injections safe and comfortable

Omeros’ OMS721 receives positive opinion from EMA's COMP for treating hematopoietic stem cell transplant

Gene regulator associated with protein pileup in exfoliation glaucoma

Ocular Therapeutix resubmits NDA for DEXTENZA

Cataract surgery linked to modest decrease in risk of serious traffic crash

EyeSouth announces strategic partnership with South Georgia / North Florida Eye Partners

FDA approves first stand-alone prosthetic iris in the U.S.

Celgene to share new and updated data around novel hematological therapies

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Cataract News and Research

Latest Cataract News and Research

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Newsletters you may be interested in